Tylenol Cold Plus Flu Plus Chest Congestion Tablet, Film Coated
NDC Package 50580-584-24
Package Information
Tylenol Cold Plus Flu Plus Chest Congestion (acetaminophen, guaifenesin) tablets is ■ do not take more than directed (see overdose warning)Adults and children 12 years and over: ■ take 2 caplets every 4 hours while symptoms last ■ do not take more than 10 caplets in 24 hours Children under 12 years:■ ask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Kenvue Brands Llc, this product is identified by NDC 50580-584 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 602617 - acetaminophen 325 MG / guaiFENesin 200 MG Oral Tablet
- RxCUI: 602617 - acetaminophen 325 MG / guaifenesin 200 MG Oral Tablet
- RxCUI: 602617 - APAP 325 MG / guaifenesin 200 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50580 - Kenvue Brands Llc
- 50580-584 - Tylenol Cold Plus Flu Plus Chest Congestion
- 50580-584-24 - 2 BLISTER PACK in 1 CARTON / 12 TABLET, FILM COATED in 1 BLISTER PACK
- 50580-584 - Tylenol Cold Plus Flu Plus Chest Congestion
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50580-584-24 identifies a specific commercial package of 2 blister pack in 1 carton / 12 tablet, film coated in 1 blister pack of Tylenol Cold Plus Flu Plus Chest Congestion, a human over the counter drug labeled by Kenvue Brands Llc. This tablet, film coated is formulated for oral use and contains acetaminophen; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kenvue Brands Llc on March 06, 2026. The current certification is valid through December 31, 2027.
How is this Kenvue Brands Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50580058424. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.